Target Name: SEZ6
NCBI ID: G124925
Review Report on SEZ6 Target / Biomarker Content of Review Report on SEZ6 Target / Biomarker
SEZ6
Other Name(s): SEZ6 variant 2 | SEZ6 variant 1 | SEZ-6 | Seizure protein 6 homolog | Seizure related 6 homolog, transcript variant 2 | hSEZ-6 | Seizure protein 6 homolog (isoform 2) | Seizure related 6 homolog, transcript variant 1 | Seizure protein 6 homolog (isoform 1) | BSRPC | seizure related 6 homolog | SEZ6_HUMAN

SEZ6: A Potential Drug Target Or Biomarker for Cancer

SEZ6 (SEZ6 variant 2) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The SEZ6 gene is located on chromosome 16 and is a member of the SOX gene family, which is known for playing a role in cell signaling and development.

SEZ6 is expressed in a variety of tissues and cells throughout the body, including the brain, pancreas, and gastrointestinal tract. It is also highly expressed in cancer tissues, which suggests that it may be involved in the development and progression of cancer.

One of the key features of SEZ6 is its role in cell signaling. SOX genes are known for their ability to regulate cell proliferation and differentiation, and SEZ6 is no exception. It has been shown to play a role in the regulation of cell growth, cell cycle progression, and apoptosis (programmed cell death).

SEZ6 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that SEZ6 is highly expressed in pancreatic cancer tissues and that inhibiting its activity may be a promising strategy for the treatment of this disease.

In addition to its potential as a drug target or biomarker, SEZ6 has also been shown to be a potential biomarker for cancer. Its high expression in cancer tissues and its involvement in cell signaling make it an attractive candidate for use as a diagnostic or predictive marker for cancer.

Furthermore, SEZ6 has also been shown to be involved in the regulation of inflammation and immune response. It has been shown to play a role in the regulation of T cell development and function, which is important for the immune response.

In conclusion, SEZ6 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases, including cancer. Its role in cell signaling and its involvement in the development and progression of various diseases make it an attractive candidate for further study. Further research is needed to fully understand the role of SEZ6 in disease and to develop effective treatments.

Protein Name: Seizure Related 6 Homolog

Functions: May play a role in cell-cell recognition and in neuronal membrane signaling. Seems to be important for the achievement of the necessary balance between dendrite elongation and branching during the elaboration of a complex dendritic arbor. Involved in the development of appropriate excitatory synaptic connectivity (By similarity)

The "SEZ6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEZ6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SEZ6L | SEZ6L2 | SF1 | SF3A1 | SF3A2 | SF3A3 | SF3A3P2 | SF3B1 | SF3B2 | SF3B3 | SF3B4 | SF3B5 | SF3B6 | SFI1 | SFMBT1 | SFMBT2 | SFN | SFPQ | SFR1 | SFRP1 | SFRP2 | SFRP4 | SFRP5 | SFSWAP | SFT2D1 | SFT2D2 | SFT2D3 | SFTA1P | SFTA2 | SFTA3 | SFTPA1 | SFTPA2 | SFTPB | SFTPC | SFTPD | SFXN1 | SFXN2 | SFXN3 | SFXN4 | SFXN5 | SGCA | SGCB | SGCD | SGCE | SGCG | SGCZ | SGF29 | SGIP1 | SGK1 | SGK2 | SGK3 | SGMS1 | SGMS1-AS1 | SGMS2 | SGO1 | SGO1-AS1 | SGO2 | SGPL1 | SGPP1 | SGPP2 | SGSH | SGSM1 | SGSM2 | SGSM3 | SGTA | SGTB | SH2B1 | SH2B2 | SH2B3 | SH2D1A | SH2D1B | SH2D2A | SH2D3A | SH2D3C | SH2D4A | SH2D4B | SH2D5 | SH2D6 | SH2D7 | SH3 domain-binding protein 1 | SH3BGR | SH3BGRL | SH3BGRL2 | SH3BGRL3 | SH3BP1 | SH3BP2 | SH3BP4 | SH3BP5 | SH3BP5-AS1 | SH3BP5L | SH3D19 | SH3D21 | SH3GL1 | SH3GL1P1 | SH3GL1P2 | SH3GL1P3 | SH3GL2 | SH3GL3 | SH3GLB1 | SH3GLB2